Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against Juno Therapeutics, Inc.
Oklahoma City, OK (July 13, 2016) – On July 12, 2016, a securities class action lawsuit was filed in the United States District Court for the Western District of Washington against Juno Therapeutics, Inc. (NASDAQ: JUNO). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which is June 4, 2016 through July 7, 2016. More specifically, this litigation was filed because the Company allegedly made misleading omissions regarding a patient death in the Phase 2 "ROCKET" trial of its lead product candidate, JCAR015. In May 2016, a patient in that trial died of a cerebral edema. Juno knew the patient death was important and consulted with the FDA about an appropriate response. Yet it failed to tell investors. On July 7, 2016, post-market, Juno disclosed that three patients had passed away during a clinical trial. On this news, Juno’s share declined to closed at $27.81 on July 8, 2016.
Plaintiff seeks to recover damages on behalf of all Juno Therapeutics, Inc. shareholders who purchased common stock during the Class Period and are therefore a member of the Class as described above. You may move the Court no later than Monday, September 12, 2016 to serve as a lead plaintiff for the entire Class. However, in order to do so, you must meet certain legal requirements pursuant to the Private Securities Litigation Reform Act of 1995.
To join this class action, click here to obtain an investor certification. Once complete, please email this form to firstname.lastname@example.org, fax to us at (405) 239-2112 or send by regular mail to Federman & Sherwood, 10205 North Pennsylvania Avenue, Oklahoma City, OK 73120, ATTN: Robin.
Posted on Wed, July 13, 2016
by Robin Hester filed under